Xylem affirms FY2026 adjusted EPS and sales guidance range

Xylem affirms FY2026 adjusted EPS guidance of $5.55–$5.70 versus a $5.54 analyst estimate, and affirms FY2026 sales guidance of $9.200B versus a $9.254B estimate.